Stopping the Spread of Oral Cancer
A single drug can have many uses. This is certainly the case for Avastin ( bevacizumab ), which is widely used to treat a number of different kinds of cancer. The drug may protect against the spread of yet another.
Advancements in Treating Advanced Breast Cancers
A great deal of exciting news has been released recently regarding novel drug combinations that extend the lives of patients living with advanced breast cancers.
FDA Revokes Approval of Breast Cancer Drug
FDA Commissioner Margaret A. Hamburg, MD, said she is revoking the agency’s approval of the breast cancer indication for Avastin ( bevacizumab ) after concluding that the drug has not been shown to be safe and effective for that use.
Cholesterol-lowering Drugs May Treat Brain Cancer
One of the most exciting frontiers in oncology is discovering molecular behavior that responds to existing drug therapies. Just such a discovery has been made regarding a deadly form of brain cancer.
FDA Alerts: Avastin
The U.S. Food and Drug Administration (FDA) is alerting health care professionals that repackaged intravitreal injections of Avastin ( bevacizumab ) have caused a cluster of serious eye infections in the Miami, Florida area.
Medicare to Pay for Prostate Cancer Drug
Medicare has announced it will pay for Provenge ( sipuleucel-T ) to treat metastatic prostate cancer. This drug extends the life of patients by about four months.
FDA Panel Rules Against Avastin - Again
In an unprecedented appeals hearing, the US Food and Drug Administration (FDA) has not changed its mind. An FDA panel voted that the drug Avastin no longer be approved for treating late-stage breast cancers.
Avastin Will Still be Covered
Even though a U.S. Food and Drug Administration (FDA) panel has voted to no longer approve Avastin ( bevacizumab ) for treating late-stage breast cancers, Medicare has indicated it will continue to pay for the drug.
FDA to Determine Fate of Breast Cancer Drug - Again
In a first ever hearing, the U.S. Food and Drug Administration is considering reversing itself on a ruling to withdraw Avastin as a drug to treat metastatic (spread outside of the primary affected organ) breast cancer.